Skip to content

Autoliv ALV Add - Incremental shares under stock-based compensation plans (in shares)

Add - Incremental shares under stock-based compensation plans (in shares) at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$2.8B+6.8%
Gross profit$526.0M+10.0%
Operating income$237.0M-6.7%
Net income$141.0M-15.6%
EPS (diluted)$1.88-12.1%

Balance sheet

See full
Cash & equivalents$342.0M+6.2%
Total debt$2.3B-0.7%
Total equity$2.6B+12.0%
Total assets$8.5B+4.4%

Cash flow

See full
Operating cash flow-$76.0M-199%
CapEx$85.0M-16.7%
Free cash flow-$161.0M-544%

Valuation

See full
Market cap$8.85B+15.0%
Enterprise value$10.76B+11.3%
P/E12.5×+1.3×
P/S0.8×+0.1×

Profitability

See full
Gross margin19.3%+0.3pp
Operating margin9.7%-0.3pp
Net margin6.5%-0.2pp
FCF margin5.3%+0.7pp

Returns & leverage

See full
Return on equity28.4%-0.3pp
Debt / equity0.9×-0.1×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by Autoliv in its filing.

Tagged under the XBRL concept us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements.

The official record: Autoliv’s 10-Q, filed April 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Autoliv's add - incremental shares under stock-based compensation plans (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Autoliv's add - incremental shares under stock-based compensation plans (in shares)?
Autoliv (ALV) reported add - incremental shares under stock-based compensation plans (in shares) of $300K in Q1 2026.
How has Autoliv's add - incremental shares under stock-based compensation plans (in shares) changed year-over-year?
Autoliv's add - incremental shares under stock-based compensation plans (in shares) increased by 50.0% year-over-year, from $200K to $300K.